IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors.
about
Targeted Therapies in Adult B-Cell MalignanciesFactors regulating immunoglobulin production by normal and disease-associated plasma cellsGenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cells.Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell.Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition.Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target.Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter.Modulation of the IL-6 Receptor α Underlies GLI2-Mediated Regulation of Ig Secretion in Waldenström Macroglobulinemia Cells.Disruption of Splenic Lymphoid Tissue and Plasmacytosis in Canine Visceral Leishmaniasis: Changes in Homing and Survival of Plasma Cells.Characterization of human FCRL4-positive B cells.Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Compensates for Interleukin-6 in Initial B Cell Activation.Network Analysis Identifies Proinflammatory Plasma Cell Polarization for Secretion of ISG15 in Human Autoimmunity.Differential effects of lenalidomide during plasma cell differentiationFactors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells.The safety of pomalidomide for the treatment of multiple myeloma.Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stageT cells and autoimmune kidney disease.The Biology of Eosinophils and Their Role in Asthma.Synovial fluid mononuclear cells provide an environment for long-term survival of antibody-secreting cells and promote the spontaneous production of anti-citrullinated protein antibodies.APRIL:TACI axis is dispensable for the immune response to rabies vaccination.A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis.Bone Marrow Mesenchymal Stem Cells Enhance the Differentiation of Human Switched Memory B Lymphocytes into Plasma Cells in Serum-Free Medium.Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.Increased Abundance of Plasmacytoid Dendritic Cells and Interferon-Alpha Induces Plasma Cell Differentiation in Patients of IgA Nephropathy.Hypoxia favors the generation of human plasma cells.Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.B-cell targeting in chronic Graft-versus-Host disease.The NF-κB Activating Pathways in Multiple Myeloma.Site-1 protease function is essential for the generation of antibody secreting cells and reprogramming for secretory activityFactors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion
P2860
Q26783195-1ABA851D-4379-4558-A935-2E021688C5CDQ27021855-A46BD45E-123F-4864-86E5-E313315F4BB3Q30886634-B0FC616C-F2F9-45B7-BD22-19E5F3BB5E95Q33741100-B220ECC9-2EFE-4CDC-B5AE-F48CF710DF6EQ33762211-A7741911-6424-4A8D-8855-9A1A906A9988Q33774610-D1855CE8-83D5-4DA0-A240-857E0023CA53Q33842381-F66A3A50-E6B9-47B0-9BFB-B920C43EF2E2Q36031506-B17EBFBF-93BB-424E-9532-1330C6F491BBQ36034698-C264451A-A212-4E55-98CC-DD3797F457BBQ36411427-C6F26E37-62FB-4462-8F3D-F0A8CCF3387BQ36524036-F590C81A-4ACA-48B4-BED5-6C9F9BF10C7FQ37153681-0A83D633-06DC-49D1-9B60-163B2EEDC28CQ37317494-F4B879CC-63E0-40FA-B322-DCCF7094610EQ38298483-A4D91255-CAE3-40B8-ABBF-05928AFC42C2Q38749362-B81888A5-7907-4ADD-A387-37893E03BDFBQ38768232-20F08942-D668-46C4-86D3-69A5DF7EFA0EQ39175811-F21A0167-DBA4-45CE-A6D4-6DCB8F980E72Q39438308-CFF63763-2844-43DB-B068-0906BBD108EBQ39858551-8F1FE642-10EA-4619-B387-267934FA7194Q40158110-9D09A7F0-451A-4814-8A20-22D040AB110BQ41066685-3A22A9C6-C191-42F1-99A9-EABFBF741859Q41500669-ED1FBE48-E2AB-4CBB-A34A-0414A57AC314Q41767679-881BE7B9-714E-4909-9758-4687318CD90FQ47971862-C56BA45B-56D6-4DC1-84EC-BF7E16EB083EQ48102522-1A8B0442-AD42-4063-83FD-F14FE6B65621Q48207902-B40262C0-80A6-4E41-9DB9-FCDAD6559334Q48253201-9241D98E-E075-41F6-AAED-7D8407AF0DCBQ49539698-BA626F59-9DF7-4D5E-A57A-B51A940477E9Q49978385-30623877-4B5C-455A-8419-8C52F760DE6DQ50044417-6F2963CC-A018-4393-8ABA-5EEE4B7D368CQ55657825-7F6006D1-180F-46B4-8E6D-9EF5F7C0B3D7Q58419183-CE23BA3B-A28F-4F4D-81DC-7D9E00560060Q58747451-8AFE9C4D-9A47-4E83-B0FB-793C9AB5A0BF
P2860
IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
IL-6 supports the generation o ...... stromal cell-soluble factors.
@en
IL-6 supports the generation o ...... stromal cell-soluble factors.
@nl
type
label
IL-6 supports the generation o ...... stromal cell-soluble factors.
@en
IL-6 supports the generation o ...... stromal cell-soluble factors.
@nl
prefLabel
IL-6 supports the generation o ...... stromal cell-soluble factors.
@en
IL-6 supports the generation o ...... stromal cell-soluble factors.
@nl
P2093
P2860
P356
P1433
P1476
IL-6 supports the generation o ...... r stromal cell-soluble factors
@en
P2093
F Guilloton
P2860
P2888
P304
P356
10.1038/LEU.2014.61
P577
2014-02-07T00:00:00Z